Edition:
United Kingdom

Krystal Biotech Inc (KRYS.OQ)

KRYS.OQ on NASDAQ Stock Exchange Capital Market

9.56USD
15 Dec 2017
Change (% chg)

$-0.77 (-7.45%)
Prev Close
$10.33
Open
$10.33
Day's High
$10.76
Day's Low
$9.55
Volume
24,258
Avg. Vol
--
52-wk High
$11.98
52-wk Low
$9.20

Latest Key Developments (Source: Significant Developments)

Krystal Biotech reports qtrly loss per share $1.26‍​
Monday, 13 Nov 2017 

Nov 13 (Reuters) - Krystal Biotech Inc :Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results.Krystal Biotech Inc qtrly loss per share $1.26‍​.Krystal Biotech Inc - ‍Currently preparing to file an investigational drug application for KB103 in Q1 of 2018​.  Full Article

Krystal Biotech says KB103 granted orphan drug designation by FDA
Tuesday, 7 Nov 2017 

Nov 7 (Reuters) - Krystal Biotech Inc :Krystal Biotech’s KB103 granted orphan drug designation by the FDA to treat patients with dystrophic epidermolysis bullosa.Krystal Biotech Inc - on track to file IND for KB103 in Q1 2018​.  Full Article

BRIEF-Krystal Biotech reports qtrly loss per share $1.26‍​

* Krystal Biotech reports that KB103 received clearance from RAC review and announces third quarter 2017 financial results